2001-March Archives by Date
Starting: Fri Mar 2 04:18:01 2001
Ending: Sat Mar 31 10:00:13 2001
Messages: 145
- [Pharm-policy] PhRMA's patient assistance program (fwd)
James Love
- [Pharm-policy] TAC Open Letter and Challenge to the IIPI President (fwd)
James Love
- [Pharm-policy] UK position on pharmaceuticals (fwd)
James Love
- [Pharm-policy] WSJ: AIDS Epidemic Puts Drug Firms Treatment vs. Profits (fwd)
Robert Weissman
- [Pharm-policy] Report on court case over South Africa Medicines nAct
James Love
- [Pharm-policy] Report ASEAN workshop on TRIPS and Pharmaceuticals
James Love
- [Pharm-policy] pharma union supports South Africa
Mike Palmedo
- [Pharm-policy] Phila. Inquirer on the Medicine Access Movement
Paul Davis
- [Pharm-policy] March 5, 1st day of the Medicines Act trial
James Love
- [Pharm-policy] Trial postponed - CPT comment (fwd)
James Love
- [Pharm-policy] AFL-CIO on Pharma 301 Submission/S.Africa case
Mike Palmedo
- [Pharm-policy] AFL-CIO challenges PhRMA demands for trade sanctions against South Africa
Robert Naiman
- [Pharm-policy] TAC/COSATU/MSF/Oxfam/CPT press release on South African court case
Toby Kasper
- [Pharm-policy] PhRMA's annual 301 submission
Mike Palmedo
- [Pharm-policy] Reuters: Kenay Will Import Cheap Generic AIDS Drugs
Mike Palmedo
- [Pharm-policy] Effect of lawsuit and demonstrations
James Love
- [Pharm-policy] Feinstein/Feingold introduce new legislation
Mike Palmedo
- [Pharm-policy] WSJ: Price War over AIDS drugs
James Love
- [Pharm-policy] CPT comment on CIPLA March 7 compulsory licensing request to the
South Africa Department of Trade and Industry
James Love
- [Pharm-policy] Formatting fixed: CPT comment on CIPLA March 7 compulsory licensing
request to the South Africa Department of Trade and Industry
James Love
- [Pharm-policy] PhRMA's annual 301 submission
Susan Finston
- [Pharm-policy] Return on Investments
MFJorge@aol.com
- [Pharm-policy] AP: WHO retracts AIDS Lawsuit Statement
Mike Palmedo
- [Pharm-policy] Phila. Inquirer on Merck
Paul Davis
- [Pharm-policy] NYT: (Cipla vs. Merck in South Africa)
Paul Davis
- [Pharm-policy] Merck Price Cuts Not for Brazil, Others
Mike Palmedo
- [Pharm-policy] Text of Feinstein/Feingold bill (S.463)
Mike Palmedo
- [Pharm-policy] NYT on CIPLA CL request
James Love
- [Pharm-policy] WSJ on CIPLA CL request
love@cptech.org
- [Pharm-policy] [breaking-the-silence] AIDS Drugs & South Africa Lawsuit: Large Protest DC March 12. Ambassador will speak
Paul Davis
- [Pharm-policy] AIDS Drugs in Africa: If Cedes to When
love@cptech.org
- [Pharm-policy] Release: AIDS Activists join SA Ambassador + Others, Demanding Treatment
(revised)
Paul Davis
- [Pharm-policy] [breaking-the-silence] AIDS Drugs & South Africa Lawsuit: Large Protest DC March 12. Ambassador will speak
Paul Davis
- [Pharm-policy] MSF's d4T campaign
James Love
- [Pharm-policy] Rachel Swarns: SA to declare AIDS and emergency and issue CL
love@cptech.org
- [Pharm-policy] NYT Editorial on funding treatment
love@cptech.org
- [Pharm-policy] WHO-WTO Secretariat Workshop on Differential Pricing and Financing of
Essential Drugs
James Love
- [Pharm-policy] WSJ on CIPLA offer
James Love
- [Pharm-policy] Sunday Times: EMERGENCY!
James Love
- [Pharm-policy] Sunday Times: EMERGENCY!
katie@CritPath.Org
- [Pharm-policy] Administrative request
James Love
- [Pharm-policy] International Red Cross on Drug Prices: "unnacceptable"
Mike Palmedo
- [Pharm-policy] Red Cross Slams Drug Firms Over Pricing Policies
Mike Palmedo
- [Pharm-policy] WP: Zoellick on trade and HIV policy
love@cptech.org
- [Pharm-policy] Guardian: Campus revolt challenges Yale over $40m Aids drug
James Love
- [Pharm-policy] (no subject)
Carolyn Green
- [Pharm-policy] Boston Globe article on Beth Israel seeking deal with drug company
James Love
- [Pharm-policy] SA options regarding compulsory licensing
James Love
- [Pharm-policy] SA case - regarding "emergency"
James Love
- [Pharm-policy] The Double Message: Emergency for others but not at home!
MFJorge@aol.com
- [Pharm-policy] TAC 13 March 2001: Questions & Answers and Letter to President]
Mike Palmedo
- [Pharm-policy] IOC Drums Support for South Africa in Drug Trial
Mike Palmedo
- [Pharm-policy] WPost: AIDS Drug Pricing Policies Protested
Robert Naiman
- [Pharm-policy] Reuters: SA rejects emergency declaration
love@cptech.org
- [Pharm-policy] Pat Sidely on SA rejection of emergency call
love@cptech.org
- [Pharm-policy] Melody Peterson: generic Buspirone approval
love@cptech.org
- [Pharm-policy] BMS gives up some patent rights in South Africa
James Love
- [Pharm-policy] Re: [Ip-health] BMS gives up some patent rights in South Africa
Zackie Achmat
- [Pharm-policy] BMS gives up some patent rights in South
Africa
Amy Kapczynski
- [Pharm-policy] BMS press releast on ddI and d4T
love@cptech.org
- [Pharm-policy] BMS gives up some patent rights in SouthAfrica
James Love
- [Pharm-policy] Data on HIV drug development background
James Love
- [Pharm-policy] Merck to offer Romania reduced HIV drug prices
James Love
- [Pharm-policy] ddI and d4T patent info
James Love
- [Pharm-policy] D4T Prices from GPO in Thailand
James Love
- [Pharm-policy] TAC Statement on Bristol-Myers Squibb's Price reductions and patent
James Love
- [Pharm-policy] Participant list for WTO/WHO meeting on differential pricing
James Love
- [Pharm-policy] TAC PRESS RELEASE: BMS CONCEDES PATENTS: MAJOR VICTORY!
James Love
- [Pharm-policy] Washington Post on BMS ddi, d4T decision
love@cptech.org
- [Pharm-policy] NYT on BMS action, also note NIH comment
James Love
- [Pharm-policy] Washington Post on Mbeki rejection of HIV emergency
love@cptech.org
- [Pharm-policy] ddI patents, WSJ story on BMS action
love@cptech.org
- [Pharm-policy] Public Funding
David Garmaise
- [Pharm-policy] EU compulsory license for IMS database
love@cptech.org
- [Pharm-policy] More of EU IMS compulsory license inquiry
love@cptech.org
- [Pharm-policy] BMS patent for ddI in Thailand
James Love
- [Pharm-policy] Health GAP to BMS: Issue a Formal, Voluntary License to All Poor
Countries
Robert Weissman
- [Pharm-policy] General question about the Medicines Act Bill
steph
- [Pharm-policy] European MPs back SA's Aids-drug fight
James Love
- [Pharm-policy] Yale researchers on d4t
love@cptech.org
- [Pharm-policy] Aspen Pharmacare
love@cptech.org
- [Pharm-policy] BBC: Bad reporting on Emergency issue
love@cptech.org
- [Pharm-policy] Prescription Games and thank you
alan train
- [Pharm-policy] EP on South Africa
James Love
- [Pharm-policy] NYTimes.com Article: The Scientist's Story
Amy Kapczynski
- [Pharm-policy] BMS costs of developing d4T
James Love
- [Pharm-policy] for Joe DiMasi... on the cost issue
James Love
- [Pharm-policy] Cuban AIDS medication
James Love
- [Pharm-policy] Jim Murray's BEUC talk on access to medicine
James Love
- [Pharm-policy] Getting prices to marginal cost
James Love
- [Pharm-policy] Jamie Love's recent false postings on the listserver
amir_attaran@harvard.edu
- [Pharm-policy] Jamie Love's recent false postings on the listserver
James Love
- [Pharm-policy] Brazil and markets for active ingredients for HIV drugs
James Love
- [Pharm-policy] Brazil and markets for active ingredients for HIV drugs
James Love
- [Pharm-policy] Maxine Waters on SA lawsuit & her bill
Mike Palmedo
- [Pharm-policy] Waters on BMS and Merck price cuts
Mike Palmedo
- [Pharm-policy] Salon on Norway event
love@cptech.org
- [Pharm-policy] Class Action Suit v. Bristol
James Love
- [Pharm-policy] Yale Daily News on patent policy
Mike Palmedo
- [Pharm-policy] proper procedure of IV administration of diazepam
DKRInc@aol.com
- [Pharm-policy] RE: Pharm-policy digest, Vol 1 #312 - 3 msgs
NDAULAIRE@globalhealth.org
- [Pharm-policy] RE: Pharm-policy digest, Vol 1 #312 - 3 msgs
Gonsalves, Gregg
- [Pharm-policy] Lumiere-Action/ Cote d' Ivoire
James Love
- [Pharm-policy] Cipla Meeting with WHO and UNAIDS
James Love
- [Pharm-policy] "Reason" abandoned...
George M. Carter
- [Pharm-policy] AFP: Price cuts have little impact on access to AIDS drugs in Uganda
Mike Palmedo
- [Pharm-policy] Query: Drug registration in a bulk procurement system
Paul Davis
- [Pharm-policy] Bulk Procuremnt Query #2
Paul Davis
- [Pharm-policy] pharmaceutical pricing
A.J. Peticolas
- [Pharm-policy] more about Kolassa book on pharm pricing
A.J. Peticolas
- [Pharm-policy] TRIPS/compulsory licensing -question
Prof. Udo Schuklenk
- [Pharm-policy] Bulk Procuremnt Query #2
msmith@Oxfam.org.uk
- [Pharm-policy] TRIPS/compulsory licensing -question
George M. Carter
- [Pharm-policy] NYT: How to Distribute AIDS Drugs
Paul Davis
- [Pharm-policy] Misinformation from JJackson on AIDS drugs and Africa
Robert Weissman
- [Pharm-policy] Re: [Ip-health] TRIPS/compulsory licensing -question
amir_attaran@harvard.edu
- [Pharm-policy] Re: [Ip-health] TRIPS/compulsory licensing -question
Amy Kapczynski
- [Pharm-policy] RE: [Ip-health] TRIPS/compulsory licensing -question
Kirsten Myhr
- [Pharm-policy] WSJ on Abbott annoucement
James Love
- [Pharm-policy] Abbott press release on its offer
Mike Palmedo
- [Pharm-policy] Comment on Abbott announcement and Norvir and Kaletra
James Love
- [Pharm-policy] NIAID press note on Norvir - March 1996
James Love
- [Pharm-policy] NYT on Abbott, also new Corp to sell d4T and other US government funded
inventions at low costs in USA and elsewhere
love@cptech.org
- [Pharm-policy] DJ: Developing Countries Seek United Stand On Health Issues
James Love
- [Pharm-policy] SA seeks changes in law on drug trials
love@cptech.org
- [Pharm-policy] Brazil AIDS Drug Dispute Courtbound
James Love
- [Pharm-policy] Letter to Secretary Thompson regarding government funded inventions
James Love
- [Pharm-policy] UK sides with drugs industry over developing world
Mike Palmedo
- [Pharm-policy] Merck v. Brazil
Mike Palmedo
- [Pharm-policy] UK sides with drugs industry over developing world
gittem01@endeavor.med.nyu.edu
- [Pharm-policy] Cuba poised to enter generic AIDS drug market
Amy Kapczynski
- [Pharm-policy] Indian HIV drug prices
James Love
- [Pharm-policy] A few items on patent disclosures regarding government support
love@cptech.org
- [Pharm-policy] CPT and d4T
Gonsalves, Gregg
- [Pharm-policy] Re: [Ip-health] CPT and d4T
James Love
- [Pharm-policy] RE: [Ip-health] CPT and d4T
Gonsalves, Gregg
- [Pharm-policy] RE: [Ip-health] CPT and d4T
Gonsalves, Gregg
- [Pharm-policy] Africa patents - Nevirapine
James Love
- [Pharm-policy] Glaxo on its Uganda patents on combinations of 3TC and AZT
James Love
- [Pharm-policy] Mozambique debate over HIV drugs
James Love
- [Pharm-policy] Brazilian Resolution on Medicines - Commission on Human Rights
James Love
- [Pharm-policy] do patents matter in Africa?
James Love
- [Pharm-policy] Oxfam letter to Univ. of Minnesota on Ziagen
Mike Palmedo
- [Pharm-policy] Merck Drops Prices in Central America
James Love
- [Pharm-policy] Latest participant list for Hosbjor Norway meeting
James Love
Last message date:
Sat Mar 31 10:00:13 2001
Archived on: Sat Mar 31 10:00:14 2001
This archive was generated by
Pipermail 0.05 (Mailman edition).